
Enervit
ENV | XMIL
Overview
Corporate Details
- ISIN(s):
- IT0004356751
- LEI:
- 8156002B06C3A4C0F436
- Country:
- Italy
- Address:
- VIALE PAPA ACHILLE, 30, 20149 MILANO
- Website:
- https://www.enervit.com/en/
- Sector:
- Health Care
- Industry:
- Pharmaceuticals
Description
Positive nutrition is part of our DNA. It has always guided our advancements in field research and deepened our passion for innovation. It drives us to study the lifestyles and eating habits of the populations that have learned to live better and longer. It allows us to anticipate the nutrition of the future. It leads us to formulate and produce ideal nutrition and supplement solutions for those who practice sports, those who are health-conscious and those who want to stay in shape. All this with a specific objective: to help everyone improve the quality of their life. For over 40 years, a passion for sports nutrition has driven our scientific research. Day after day, thanks to this unique experience we invent, test, develop and produce high-quality functional foods and innovative supplements. Ours is a fully in-house approach to satisfying the nutritional needs of those who practice sports, those who are health-conscious and those who want to stay in shape.
Market Data
Market Data Not Available
Financials & KPIs
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Filings
Date | Filing | Language | Size | Actions |
---|---|---|---|---|
2025-05-14 14:19 |
Earnings Release
CS Dati Trimestrali Vendite al 31 marzo 2025
|
Italian | 321.3 KB | |
2025-04-28 13:01 |
Notice of Dividend Amount
AVVISO pagamento Dividendo Esercizio 2024
|
Italian | 146.3 KB | |
2025-04-28 12:59 |
AGM Report
Rendiconto Sintetico delle Votazioni
|
Italian | 219.2 KB | |
2025-04-28 12:57 |
AGM Report
CS post Assemblea Ordinaria del 28.04.2025
|
Italian | 273.4 KB | |
2025-04-07 11:25 |
Report Publication Announcement
Avviso su quot Deposito Rel Fin Annuale
|
Italian | 582.8 KB | |
2025-04-07 11:23 |
Report Publication Announcement
CS - Deposito Relazione Finanziaria Annuale
|
Italian | 164.3 KB | |
2025-04-07 11:07 |
Corporate Governance Report
Relazione sul Governo Societario Assemblea 2025 Esercizio 2024
|
Italian | 991.9 KB | |
2025-04-07 11:05 |
Remuneration Report
Relazione sulla Remunerazione
|
Italian | 710.3 KB | |
2025-03-19 14:18 |
Proxy Solicitation & Information Statements
Delega RD Undecies
|
Italian | 437.0 KB | |
2025-03-19 14:17 |
Proxy Solicitation & Information Statements
Delega a RD Novies
|
Italian | 387.6 KB | |
2025-03-19 14:12 |
General Meeting Notice
ESTRATTO avviso di convocazione Assemblea Ordinaria
|
Italian | 157.1 KB | |
2025-03-19 14:10 |
AGM Report
Relazione illustrativa sulle materie all'ordine del giorno
|
Italian | 9.8 MB | |
2025-03-19 14:08 |
Declaration of Voting Results & Voting Rights Announcements
AVVISO di convocazione Assemblea ordinaria
|
Italian | 204.5 KB | |
2025-03-19 14:06 |
Earnings Release
CS - CDA approva il progetto di bilancio
|
Italian | 491.6 KB | |
2025-01-07 17:20 |
General Meeting Notice
verbale assemblea straordinaria 16.12.2024
|
Italian | 2.4 MB |
Insider Transactions
Date | Insider Name | Position | Type | Shares | Value |
---|---|---|---|---|---|
No insider transactions recorded for this company. |
Peer Companies
Company | Country | Ticker | View | |
---|---|---|---|---|
![]() |
ABIVAX | France | ABVX | |
|
Addex Therapeutics Ltd | Switzerland | ADXN | |
![]() |
AegirBio AB | Sweden | AEGIR | |
|
AGRONOMICS LIMITED | Isle of Man | ANIC | |
![]() |
AIREA PLC | United Kingdom | AIEA | |
|
Alkaloid AD | North Macedonia | ALK | |
Alma Yesodot Ltd. | Israel | KVSR | ||
![]() |
Amphastar Pharmaceuticals Inc. | United States of America | AMPH | |
Ananda Pharma Plc | United Kingdom | N/A | ||
![]() |
Antibiotice S.A. | Romania | ATB |